Intended for US Audiences Only

 

Connect With Us

    Nathan's IXperience

    Watch Nathan's IXperience.

    This information is based on Nathan's experience. Different patients may have different results. Talk to your doctor about whether IXINITY may be right for you.

    9 reasons why IXINITY was right for Nathan

    Bleed Control Counts


    "The fact that I could treat a bleed with just 1 infusion was huge for me."

    In a clinical trial, 71% of bleeding episodes were resolved with 1 infusion and 13% were resolved with 2 infusions.1 Individual response may vary.

    Small Wins, Big Impact


    "With the 24-hour half-life of IXINITY, I don't have to infuse as often. And when it comes to managing my hemophilia, even a small difference can be a big deal."

    The average terminal half-life of IXINITY is 24 hours.1 Individual response may vary.

    Control Confidence


    "Before, I wouldn't participate in certain activities because I just didn't feel like I was covered. But after switching to IXINITY, I started jogging and lifting weights."

    Consult a healthcare professional before beginning new activities.

    Flexible Coverage


    "I like that I can plan my infusions on days when I want to do more challenging workouts, but I don't have to worry if I still want to do some activities the next day."

    Just the Facts


    "I was intrigued by the numbers. There were no inhibitors found in the clinical trials, recovery rate was 98%, and it's not a plasma-derived product, so I was pretty impressed."

    IXINITY recovery is an average based on lab tests of patients in the clinical study.1 Your actual recovery and dose may be different. Speak with your healthcare professional about the right dose for you.

    Know the Facts


    "I can definitely say it's crucial that you do your research before talking to a healthcare professional. I think it helped that I knew the facts about the product and was passionate about wanting to switch."

    Feeling Free to Just B


    "My outlook in general has definitely changed, and I'm more open about having hemophilia because I'm not feeling held back by it."

    Community Commitment


    "I really love what Medexus does for the community, especially their commitment to giving back with programs like Factor It Forward™."

    Less Is More


    "With IXINITY, I'm only infusing 4,000 IU, which is great for me. It was higher in the past."

    IXINITY has an average incremental recovery of 98%. Higher recovery may allow lower doses.1 Individual response may vary.

    This information is based on Nathan’s experience. Different patients may have different results. Talk to your doctor about whether IXINITY may be right for you.

    Selected Important Safety Information
    Call your healthcare provider right away about any side effects that bother you or do not go away, or if your bleeding does not stop after taking IXINITY. The most common side effect that was reported with IXINITY during clinical trials was headache. These are not all the side effects possible with IXINITY. You can ask your healthcare provider for information that is written for healthcare professionals.

    Reference: 1. IXINITY [coagulation factor IX (recombinant)] prescribing information. Chicago, IL: Medexus Pharma, Inc.; March 2024.

    Since switching, I’m more willing to just jump in and go because I’m confident that I’m covered with IXINITY®.

    Questions? Connect with a Hemophilia Territory Manager

    Call 1-855-IXINITY (1-855-494-6489) to speak with your Concierge at Core Connections for more information on IXINITY.

    Medexus Pharma, Inc., Chicago, IL 60606

    IXINITY [coagulation factor IX (recombinant)] and any and all Medexus Pharma, Inc. brand, product, service and feature names, logos, and slogans are trademarks or registered trademarks of Medexus Pharma, Inc. in the United States and/or other countries.

    ©2024 Medexus Pharma, Inc.
    All rights reserved. MP-IX-0525

    INDICATIONS AND IMPORTANT SAFETY INFORMATION

    Expand

    What is IXINITY?

    IXINITY [coagulation factor IX (recombinant)] is a medicine used to replace clotting factor (factor IX) that is missing in adults and children with hemophilia B. Hemophilia B is also called congenital factor IX deficiency or Christmas disease. Hemophilia B is an inherited bleeding disorder that prevents clotting. For children and adults, your healthcare provider may give you IXINITY for on-demand treatment and control of bleeding episodes, when you have surgery, or for routine prophylaxis to prevent bleeding episodes.

    IXINITY is not indicated for induction of immune tolerance in patients with hemophilia B.

    IMPORTANT SAFETY INFORMATION for IXINITY

    • You should not use IXINITY if you are allergic to hamsters or any ingredients in IXINITY.

    • You should tell your healthcare provider if you have or have had medical problems, take any medicines, including prescription and non-prescription medicines, such as over-the-counter medicines, supplements, or herbal remedies, have any allergies, including allergies to hamsters, are nursing, are pregnant or planning to become pregnant, or have been told that you have inhibitors to factor IX.

    • You can experience an allergic reaction to IXINITY. Contact your healthcare provider or get emergency treatment right away if you develop a rash or hives, itching, tightness of the throat, chest pain, or tightness, difficulty breathing, lightheadedness, dizziness, nausea, or fainting.

    • Your body may form inhibitors to IXINITY. An inhibitor is part of the body's defense system. If you develop inhibitors, it may prevent IXINITY from working properly. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for development of inhibitors to IXINITY.

    • If you have risk factors for developing blood clots, the use of IXINITY may increase the risk of abnormal blood clots.

    • Call your healthcare provider right away about any side effects that bother you or do not go away, or if your bleeding does not stop after taking IXINITY.

    • The most common side effect that was reported with IXINITY during clinical trials was headache.

    • These are not all the side effects possible with IXINITY. You can ask your healthcare provider for information that is written for healthcare professionals.


    For more information about IXINITY, please see full Prescribing Information.

    You are encouraged to report adverse events related to Medexus Pharma products by calling 1-844-859-6675. If you prefer, you may contact the Food and Drug Administration directly. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.